Back
Lithium Americas Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Buy
53
LAC
Lithium Americas
Last Price:
4.39
Seasonality Move:
12.03%
Buy
62
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
43.91
Seasonality Move:
-8.14%
Buy
53
Lithium Americas (LAC)
is a Buy
Is Lithium Americas a Buy, Sell or Hold?
- The current Lithium Americas [LAC] share price is $4.57. The Score for LAC is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- LAC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Corbus Pharmaceuticals Holdings (CRBP)
is a Buy
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $42.99. The Score for CRBP is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- CRBP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LAC Stock Price Chart
What is Lithium Americas's stock price today?
-
The Lithium Americas share price today is $4.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LAC is experiencing slight buying pressure.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $42.99
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRBP is experiencing slight selling pressure.
LAC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.39 | Sell |
| Relative Strength Index (14 RSI): | 40.85 | Sell |
| Chaikin Money Flow: | 2103001 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.04 - 6.14) | Sell |
| Bollinger Bands (100): | (4.38 - 6.38) | Sell |
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.47 | Buy |
| Relative Strength Index (14 RSI): | 62.31 | Buy |
| Chaikin Money Flow: | -1858 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.15 - 41.83) | Buy |
| Bollinger Bands (100): | (14.29 - 41.49) | Buy |
LAC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.45 | Buy |
| 20-day SMA: | 4.62 | Sell |
| 50-day SMA: | 5.68 | Sell |
| 200-day SMA: | 6.42 | Sell |
| 8-day EMA: | 4.48 | Buy |
| 20-day EMA: | 4.8 | Sell |
| 50-day EMA: | 5.27 | Sell |
| 200-day EMA: | 6.3 | Sell |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.53 | Buy |
| 20-day SMA: | 38.59 | Buy |
| 50-day SMA: | 39.21 | Buy |
| 200-day SMA: | 16.92 | Buy |
| 8-day EMA: | 41.61 | Buy |
| 20-day EMA: | 39.84 | Buy |
| 50-day EMA: | 36.59 | Buy |
| 200-day EMA: | 22.08 | Buy |
Lithium Americas Earnings Growth & LAC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.11 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.55 per share, an increase next quarter of $0.28 per share, an increase this year of $5.53 per share, and an increase next year of $0.35 per share.
Lithium Americas Technical Analysis
| May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corbus Pharmaceuticals Holdings Technical Analysis
| May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||